Close

Bicycle Therapeutics (BCYC) PT Raised to $32 at Jefferies After Adding BT5528 Opportunity to Model

January 15, 2021 9:09 AM EST Send to a Friend
Jefferies analyst Biren Amin raised the price target on Bicycle Therapeutics (NASDAQ: BCYC) to $32.00 (from $22.00) on early encouraging ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login